Komori
Astena Holdings (8095) · InitiativeRestated

Preparations for the transition to a holding company structure and establishment of a company to be created through the corporate split

First written in FY2020-Q3. 2 of 5 entries say "Advanced", first in FY2020. Latest entry: FY2021-Q3.

5entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020-Q3AdvancedFY2020 – FY2021-Q22020: 120202021: 42021
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021-Q3RestatedAnnual report

    「The Company transitioned to a holding company structure effective 1 June 2021, changing its corporate name from IWAKI CO.,LTD. to Astena Holdings Co.,Ltd. at the same time. IWAKI Split Preparation Co., Ltd. also changed its corporate name to IWAKI CO.,LTD.」

    The transition to a holding company structure through the absorption-type company split effective 1 June 2021 and the corporate name change were also confirmed in the quarterly securities report for the current quarter.
  2. FY2021-Q2AchievedAnnual report

    「Based on the absorption-type company split agreements approved at the Company's board meeting held on 22 January 2021, including the agreement between the Company and its 3 wholly owned subsidiaries, the agreement between its wholly owned subsidiaries, and the agreements between the Company and 1 of its wholly owned subsidiaries and its wholly owned subsidiary スペラファーマ株式会社, the Company carried out the absorption-type company splits effective 1 June 2021 and transitioned to a holding company structure.」

    The Company carried out multiple absorption-type company splits effective 1 June 2021, completing its transition to a holding company structure. Its corporate name was also changed to Astena Holdings Co.,Ltd.
  3. FY2021-Q1AdvancedAnnual report

    「At a meeting of its board of directors held on 22 January 2021, the Company resolved to approve the execution of absorption-type company split agreements with its 3 wholly owned subsidiaries, the execution of an absorption-type company split agreement between its wholly owned subsidiaries, and the execution of absorption-type company split agreements between the Company and 1 of its wholly owned subsidiaries and its wholly owned subsidiary スペラファーマ株式会社. The agreements were executed on the same date.」

    In preparation for the transition to a holding company structure, the Company executed multiple absorption-type company split agreements. The planned date was 1 June 2021, and the related proposals were approved at the general meeting of shareholders on 24 February 2021.
  4. FY2020AdvancedAnnual report

    「Following the absorption-type company split, the Company resolved at a meeting of its board of directors held on the same date to change its corporate name to Astena Holdings Co.,Ltd. effective 1 June 2021 (scheduled), and to amend its business purpose to reflect its business after the transition to a holding company structure. The related proposals were approved at the Company's general meeting of shareholders held on 24 February 2021.」

    The absorption-type company split agreement, corporate name change and amendment to the business purpose for the transition to a holding company structure were approved, and the related proposals proceeded to shareholder approval. The planned date is 1 June 2021.
  5. FY2020-Q3First statedAnnual report

    「As part of preparations for the transition to a holding company structure, the Company newly established IWAKI Split Preparation Co., Ltd. on 21 July 2020, while its consolidated subsidiary スペラファーマ株式会社 newly established スペラネクサス株式会社. Both companies have been included in the scope of consolidation from the third quarter of the current consolidated fiscal year.」

    As part of preparations for the transition to a holding company structure, the Company established IWAKI Split Preparation Co., Ltd. and スペラネクサス株式会社 on 21 July 2020 and included both in the scope of consolidation.
Moved together

"Overseas Expansion and Product Development in Chemicals, New Equipment and Optimal-Site Production" moved the same way as this thread, in the same document, in 3 of its 5 moves.

333333★123456
  1. ★This thread
  2. 1Overseas Expansion and Product Development in Chemicals, New Equipment and Optimal-Site Production3×
  3. 2Sharp Decline in Chemicals Business Revenue and Widening Operating Loss3×
  4. 3Expanding Sales of Generic Pharmaceutical Ingredients and New Materials Through Customer Proposals3×
  5. 4Strengthening the CMC contract research business through the acquisition of all shares in スペラファーマ3×
  6. 5Strengthening Direct Marketing Through the Acquisition of All Shares in マルマンH&B3×
  7. 6Stable Supply of Pharmaceuticals, Capital Investment and Production Efficiency Improvements3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Astena Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Preparations for the transition to a holding company structure and establishment of a company to be created through the corporate split | Astena Holdings Co.,Ltd. (8095) | Komori